GR980100096A - Νεα συνθεση βαλσαλαζιδης - Google Patents

Νεα συνθεση βαλσαλαζιδης

Info

Publication number: GR980100096A
Authority: GR; Greece
Prior art keywords: balsalazide; new formulation; formulation; hydroxy; density
Prior art date: 1997-03-14

Application number

GR980100096A

Other languages

English (en)

Inventor

Harald Heckenmuller

Stefan Friess

Oliver Szambien

Original Assignee

Astra Aktiebolag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-03-14

Filing date

1998-03-06

Publication date

1998-11-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20406161&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR980100096(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-03-06 Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag

1998-11-30 Publication of GR980100096A publication Critical patent/GR980100096A/el

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

GR980100096A 1997-03-14 1998-03-06 Νεα συνθεση βαλσαλαζιδης GR980100096A (el)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE9700934A SE9700934D0 (sv)	1997-03-14	1997-03-14	New formulation

Publications (1)

Publication Number	Publication Date
GR980100096A true GR980100096A (el)	1998-11-30

Family

ID=20406161

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GR980100096A GR980100096A (el)	1997-03-14	1998-03-06	Νεα συνθεση βαλσαλαζιδης

Country Status (15)

Country	Link
US (1)	US6197341B1 (el)
EP (1)	EP1003524A1 (el)
JP (1)	JP2001519782A (el)
AU (1)	AU6430198A (el)
BE (1)	BE1011837A5 (el)
BR (1)	BR9808140A (el)
CA (1)	CA2283297A1 (el)
FR (1)	FR2760638A1 (el)
GR (1)	GR980100096A (el)
HU (1)	HUP0000850A3 (el)
NL (1)	NL1008575C2 (el)
NO (1)	NO994431D0 (el)
PL (1)	PL335700A1 (el)
SE (1)	SE9700934D0 (el)
WO (1)	WO1998041212A1 (el)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9700934D0 (sv) *	1997-03-14	1997-03-14	Astra Ab	New formulation
JP5112595B2 (ja) *	2000-08-29	2013-01-09	バイオコン・リミテッド	抗炎症活性および抗生物質活性を有する５−ａｓａ誘導体およびこれを用いて疾患を治療する方法
DK1642885T3 (da) *	2000-08-29	2010-01-04	Biocon Ltd	Anvendelse af et farmaceutisk præparat der indeholder et para-aminophenyl-eddikesyrederivat til behandling af inflammatoriske tilstande i mave-tarmkanalen
US8048924B2 (en) *	2001-08-29	2011-11-01	Biocon Limited	Methods and compositions employing 4-aminophenylacetic acid compounds
MY140707A (en) *	2002-02-28	2010-01-15	Mitsubishi Tanabe Pharma Corp	Process for preparing a phenylalanine derivative and intermediates thereof
ZA200607435B (en)	2004-02-06	2009-05-27	Pharmatel Red Pty Ltd As The T	Use of aminosalicylates in diarrhoea-predominant irritable bowel syndrome
US20080306029A1 (en) *	2004-05-28	2008-12-11	Salix Pharmaceuticals, Inc.	Prevention, Treatment, and Amelioration of Radiation Induced Enteritis
CA2556373C (en) *	2004-05-28	2012-09-04	Salix Pharmaceuticals, Inc.	Prevention, treatment, and amelioration of radiation induced enteritis
HUE028158T2 (en)	2004-07-07	2016-12-28	Biocon Ltd	Synthesis of bound immunoregulatory compounds
US7741359B2 (en) *	2005-05-27	2010-06-22	Antibe Therapeutics Inc.	Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs
WO2006125293A1 (en) *	2005-05-27	2006-11-30	Antibe Therapeutics Inc.	Derivatives of 4- or 5-aminosalicylic acid
US7498355B2 (en) *	2005-05-27	2009-03-03	Antibe Therapeutics Inc.	Derivatives of 4- or 5-aminosalicylic acid
US20060270635A1 (en) *	2005-05-27	2006-11-30	Wallace John L	Derivatives of 4- or 5-aminosalicylic acid
CN102670626A (zh)	2005-08-24	2012-09-19	萨利克斯药品公司	巴柳氮制剂及其生产和应用
US8921344B2 (en)	2006-11-03	2014-12-30	Salix Pharmaceuticals, Inc.	Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
US7452872B2 (en) *	2005-08-24	2008-11-18	Salix Pharmaceuticals, Inc.	Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
CN101489986A (zh) *	2006-06-06	2009-07-22	安泰碧治疗公司	曲美布汀和n-去甲基曲美布汀的盐
EP2563117B1 (en)	2010-04-26	2018-02-21	Salix Pharmaceuticals, Ltd.	Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males
US12053447B2 (en)	2019-06-25	2024-08-06	NuBioPharma, LLC	Oral solution and powder to liquid compositions of balsalazide

Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1981002671A1 (en) *	1980-03-20	1981-10-01	Ferring Farma Lab	Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration
GB2080796A (en) *	1980-07-21	1982-02-10	Biorex Laboratories Ltd	2-Hydroxy-5-phenylazobenzoic acid derivatives
US5316772A (en) *	1990-12-19	1994-05-31	Solvay & Cie, S.A. (Societe Anonyme)	Bilayered oral pharmaceutical composition with pH dependent release
WO1995018622A1 (en) *	1994-01-07	1995-07-13	Salix Pharmaceuticals, Inc.	Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents
WO1998041212A1 (en) *	1997-03-14	1998-09-24	Astra Aktiebolag (Publ)	New formulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4045429A (en)	1970-03-06	1977-08-30	Pharmacia Aktiebolag	4-(4-Hydroxy- or acetoxy-3-carbomethoxyphenylazo)-benzenesulphonyl chloride
BE791889A (fr)	1971-11-26	1973-05-24	Pharmacia Ab	Nouveaux derives de la pyridine
US4412992A (en)	1980-07-21	1983-11-01	Biorex Laboratories Limited	2-Hydroxy-5-phenylazobenzoic acid derivatives and method of treating ulcerative colitis therewith
SE9003296L (sv) *	1990-10-16	1992-04-17	Kabi Pharmacia Ab	Foerfarande foer att formulera laekemedel

1997
- 1997-03-14 SE SE9700934A patent/SE9700934D0/xx unknown
1998
- 1998-03-06 GR GR980100096A patent/GR980100096A/el unknown
- 1998-03-12 FR FR9803077A patent/FR2760638A1/fr not_active Withdrawn
- 1998-03-12 NL NL1008575A patent/NL1008575C2/nl not_active IP Right Cessation
- 1998-03-13 CA CA002283297A patent/CA2283297A1/en not_active Abandoned
- 1998-03-13 JP JP54042198A patent/JP2001519782A/ja active Pending
- 1998-03-13 BR BR9808140-3A patent/BR9808140A/pt not_active IP Right Cessation
- 1998-03-13 PL PL98335700A patent/PL335700A1/xx unknown
- 1998-03-13 HU HU00008500000850A patent/HUP0000850A3/hu unknown
- 1998-03-13 EP EP98909944A patent/EP1003524A1/en not_active Withdrawn
- 1998-03-13 AU AU64301/98A patent/AU6430198A/en not_active Abandoned
- 1998-03-13 WO PCT/SE1998/000455 patent/WO1998041212A1/en not_active Application Discontinuation
- 1998-03-13 BE BE9800201A patent/BE1011837A5/fr not_active IP Right Cessation
- 1998-05-14 US US09/068,823 patent/US6197341B1/en not_active Expired - Lifetime
1999
- 1999-09-13 NO NO994431A patent/NO994431D0/no unknown

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1981002671A1 (en) *	1980-03-20	1981-10-01	Ferring Farma Lab	Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration
GB2080796A (en) *	1980-07-21	1982-02-10	Biorex Laboratories Ltd	2-Hydroxy-5-phenylazobenzoic acid derivatives
US5316772A (en) *	1990-12-19	1994-05-31	Solvay & Cie, S.A. (Societe Anonyme)	Bilayered oral pharmaceutical composition with pH dependent release
WO1995018622A1 (en) *	1994-01-07	1995-07-13	Salix Pharmaceuticals, Inc.	Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents
WO1998041212A1 (en) *	1997-03-14	1998-09-24	Astra Aktiebolag (Publ)	New formulation

Also Published As

Publication number	Publication date
SE9700934D0 (sv)	1997-03-14
NO994431L (no)	1999-09-13
EP1003524A1 (en)	2000-05-31
HUP0000850A3 (en)	2000-10-30
NL1008575C2 (nl)	1999-09-10
WO1998041212A1 (en)	1998-09-24
CA2283297A1 (en)	1998-09-24
FR2760638A1 (fr)	1998-09-18
AU6430198A (en)	1998-10-12
JP2001519782A (ja)	2001-10-23
NO994431D0 (no)	1999-09-13
US6197341B1 (en)	2001-03-06
PL335700A1 (en)	2000-05-08
BE1011837A5 (fr)	2000-02-01
HUP0000850A2 (hu)	2000-09-28
NL1008575A1 (nl)	1998-09-15
BR9808140A (pt)	2000-03-28

Similar Documents

Publication	Publication Date	Title
GR980100096A (el)	1998-11-30	Νεα συνθεση βαλσαλαζιδης
DE69905368D1 (en)	2003-03-20	Oxydiertes thymosin beta 4
EP1045636A4 (en)	2003-09-10	PHARMACEUTICAL COMPOSITIONS AND METHOD OF USING THE SAME FOR TREATING FAILURE MYOCARDIAL TISSUES
NO20000688D0 (no)	2000-02-11	Anvendelse av lokalt avleverte metallioner for behandling av periodontal sykdom
FI20000720L (fi)	2000-03-29	Pitkitettyyn vapautumiseen perustuva tablettiformulaatio Parkisonin taudin hoitamiseksi
BG104476A (en)	2000-12-29	Therapeutical form for tolterodin with controlled release
GR1003011B (el)	1998-11-20	Νεα συνθεση
HK1037861A1 (en)	2002-02-22	Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention
IL132608A0 (en)	2001-03-19	Fused dihydropyran compounds medicaments containing the same and the use thereof
DE69429202D1 (de)	2002-01-10	Therapeutischer Wirkstoff für Erkrankungen des Verdauungstraktes
HU9603042D0 (en)	1997-01-28	Use of certain methanebisphosphonic acid derivatives to prevent or for treatment of prosthesis loosening and prosthesis migration
EP1073416A4 (en)	2004-07-07	USE OF INHAL NITRIC OXIDE AS ANTI-INFLAMMATORY AGENT
IL131407A0 (en)	2001-01-28	Tetrahydropyrido compounds medicaments containing the same and the use thereof
IL125913A0 (en)	1999-04-11	Pharmaceutical combination preparation of an inhibitor of the sodium/hydrogen exchanger and medicament for the treatment of cardio-vascular diseases
UA26973A1 (uk)	2000-02-28	Засіб для профілактики судиhhих захворюваhь, які обумовлеhі дією глікопротеїhзв'язаhих пероксидів
AU7728698A (en)	1998-12-30	Oral formulations for treatment of bacteria-induced diseases of the colon
TR200000455T2 (tr)	2000-09-21	Alzheimer hastalığının tedavisinde fankinonun kullanılması.
IL118218A (en)	1999-10-28	Pharmaceutical compositions containing sarcodictyins
AU5397496A (en)	1996-10-16	Low dose ridogrel formulations and their use for the treatme nt of inflammatory bowel diseases
GB9420747D0 (en)	1994-11-30	1,5 benzodiazepine derivatives
KR100488038B1 (ko)	2005-05-09	기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
FI952953L (fi)	1995-12-18	Aineita metabolisten luustosairauksien hoitamiseen
TR199700921T1 (xx)	1998-02-21	�nsanlarda g�r�len herpes-vir�s-8'in tedavisinde pensiklovir'in kullan�lmas�.
ITRM970235A0 (it)	1997-04-23	Catetere per la diagnosi e il trattamento dell'eiaculazione precoce
HUP9801985A3 (en)	2000-07-28	Use of cystine derivatives for the preparation of pharmaceutical compositions useful for the treatment of restenosis